Zevra Therapeutics, Inc. (ZVRA)
NASDAQ·Healthcare·Biotechnology
$10.22
+1.44%
Mkt Cap $621.75M
Analyst Ratings
Buy
13
Hold
0
Sell
0
Price Target (19 analysts)
$25.75
Range $20.00 – $35.00
Implied Upside
+152.1%
Consensus $25.75 vs current $10.22
NASDAQ·Healthcare·Biotechnology
$10.22
+1.44%
Mkt Cap $621.75M
Buy
13
Hold
0
Sell
0
Price Target (19 analysts)
$25.75
Range $20.00 – $35.00
+152.1%
Consensus $25.75 vs current $10.22